You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

taselisib

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Taselisib
  • +4 more
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Taselisib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Taselisib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Feb 4, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Treating Recurrent Stage IV Squamous Cell Lung Cancer

Active, not recruiting
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
  • Birmingham, Alabama
  • +1003 more
Nov 29, 2021

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma Trial in Canada, United States (Laboratory

Completed
Has Results
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma
  • Laboratory Biomarker Analysis
  • Taselisib
  • Birmingham, Alabama
  • +1110 more
Sep 29, 2020

Breast Cancer Trial in Worldwide (Letrozole, Placebo, Taselisib)

Completed
Has Results
  • Breast Cancer
  • Santa Ana, California
  • +116 more
Apr 20, 2018

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022